Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rożek, P.
236  Ergebnisse:
Personensuche X
?
1

ATR/FT-IR studies of zeolite formation during alkali-activa..:

Król, M. ; Rożek, P. ; Chlebda, D..
Solid State Sciences.  94 (2019)  - p. 114-119 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Influence of alkali metal cations/type of activator on the ..:

Król, M. ; Rożek, P. ; Chlebda, D..
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.  198 (2018)  - p. 33-37 , 2018
Link: https://doi.org/10.1016/..
 
?
3

Majorana-Based Fermionic Quantum Computation:

O'Brien, T. E. ; Rożek, P. ; Akhmerov, A. R.
Physical Review Letters.  120 (2018)  22 - p. , 2018
Link: https://doi.org/10.1103/..
 
?
4

Disposal of bottom ash from the incineration of hazardous w..:

Rożek, P. ; Król, M. ; Knapik, A..
Environmental Progress & Sustainable Energy.  36 (2017)  4 - p. 1074-1082 , 2017
Link: https://doi.org/10.1002/..
 
?
5

Ground-state and finite-temperature properties of correlate..:

Sajna, A. S. ; Polak, T. P. ; Micnas, R..
Physical Review A.  92 (2015)  1 - p. , 2015
Link: https://doi.org/10.1103/..
 
?
6

Learning-Induced Plasticity Enhances the Capacity of Visual..:

Conci, Markus ; Busch, Nuno ; Rozek, Robert P..
Psychological Science.  34 (2023)  10 - p. 1087-1100 , 2023
Link: https://doi.org/10.1177/..
 
?
7

Valuing the Residual Intellectual Property in Mature Pharma..:

ROZEK, Richard P
European Journal of Risk Regulation.  9 (2018)  2 - p. 337-350 , 2018
Link: https://doi.org/10.1017/..
 
?
8

Valuing the Residual Intellectual Property in Mature Pharma..:

ROZEK, Richard P
European Journal of Risk Regulation.  9 (2018)  2 - p. 337-350 , 2018
Link: https://www.jstor.org/st..
 
?
9

Economic Analysis of the Risks Associated with Seeking a Pr..:

Rozek, Richard P.
European Journal of Risk Regulation.  7 (2016)  1 - p. 206-212 , 2016
Link: https://doi.org/10.1017/..
 
?
10

Economic Analysis of the risks Associated with Seeking a Pr..:

Rozek, Richard P.
European Journal of Risk Regulation.  7 (2016)  1 - p. 206-212 , 2016
Link: http://www.jstor.org/sta..
 
?
11

Risks Associated with Litigating or Settling Pharmaceutical..:

Rozek, Richard P.
European Journal of Risk Regulation.  5 (2014)  2 - p. 223-227 , 2014
Link: https://doi.org/10.1017/..
 
?
12

Assessing the Commercial Success of a Pharmaceutical Produc..:

Rozek, Richard P.
European Journal of Risk Regulation.  5 (2014)  3 - p. 380-385 , 2014
Link: https://doi.org/10.1017/..
 
?
13

Risks Associated with Litigating or Settling Pharmaceutical..:

Rozek, Richard P.
European Journal of Risk Regulation.  5 (2014)  2 - p. 223-227 , 2014
Link: https://www.jstor.org/st..
 
?
14

Assessing the Commercial Success of a Pharmaceutical Produc..:

Rozek, Richard P.
European Journal of Risk Regulation.  5 (2014)  3 - p. 380-385 , 2014
Link: https://www.jstor.org/st..
 
?
15

Switching Pharmaceutical Products from Prescription to Over..:

Rozek, Richard P.
European Journal of Risk Regulation.  3 (2012)  4 - p. 601-607 , 2012
Link: https://doi.org/10.1017/..
 
1-15